LA3382 is a temperature-sensitive replication-defective mutant of Rous sarcoma virus that contains four active mutations. In this study we performed experiments to determine the biochemical defect that blocks the synthesis of infectious virus late in the replication cycle. At the nonpermissive temperature (410C) cells infected with LA3382 synth-esized virus particles which were noninfectious and exhibited significant reductions in the amounts of gp85 and gp37 present in the virions. An analysis of the intracellular viral polypeptides indicated that the precursor of the viral glycoproteins (Pr95) was synthesized normally but underwent cleavage at a reduced rate at the restrictive temperature. Pr95 did not accumulate in infected cells and was inserted into mutant virions at 410C; however, Pr95 was cleaved in such a way that gp85 was released from the viruses and could be detected in the supernatant medium by immunoprecipitation. The virus-free glycoprotein was indistinguishable from wild-type gp85 and may have been released due to an anomalous cleavage. Pulse-chase experiments also indicated that the Prl80 polyprotein precursor of the reverse transcriptase was cleaved to the active form of the enzyme more slowly at 410C in LA3382-infected cells. This accounted for the twofold lower level of polymerase activity found in mutant virions at 410C, a defect which probably did not account for the observed 20-to 50-fold reduction in infectivity. Furthermore, the replication defect was not complemented by an env deletion mutant Rous sarcoma virus [RSV(-)], which should complement a pol defect. Therefore, we concluded that the major lesion that impairs replication in LA3382 is within the env gene.
LA3382 is a temperature-sensitive replication-defective mutant of Rous sarcoma virus that contains four active mutations. In this study we performed experiments to determine the biochemical defect that blocks the synthesis of infectious virus late in the replication cycle. At the nonpermissive temperature (410C) cells infected with LA3382 synth-esized virus particles which were noninfectious and exhibited significant reductions in the amounts of gp85 and gp37 present in the virions. An analysis of the intracellular viral polypeptides indicated that the precursor of the viral glycoproteins (Pr95) was synthesized normally but underwent cleavage at a reduced rate at the restrictive temperature. Pr95 did not accumulate in infected cells and was inserted into mutant virions at 410C; however, Pr95 was cleaved in such a way that gp85 was released from the viruses and could be detected in the supernatant medium by immunoprecipitation. The virus-free glycoprotein was indistinguishable from wild-type gp85 and may have been released due to an anomalous cleavage. Pulse-chase experiments also indicated that the Prl80 polyprotein precursor of the reverse transcriptase was cleaved to the active form of the enzyme more slowly at 410C in LA3382-infected cells. This accounted for the twofold lower level of polymerase activity found in mutant virions at 410C, a defect which probably did not account for the observed 20-to 50-fold reduction in infectivity. Furthermore, the replication defect was not complemented by an env deletion mutant Rous sarcoma virus [RSV(-)], which should complement a pol defect. Therefore, we concluded that the major lesion that impairs replication in LA3382 is within the env gene.
The isolation and characterization of temperature-sensitive mutants of avian sarcoma viruses have led to the identification of the molecular functions that are encoded on the viral genome (5, 22, 24) . One such mutant of Rous sarcoma virus (RSV) Prague strain subgroup C (PR-C) is LA338, which appears to contain four defects. One of these affects an early function (before integration into the host genome) that impairs both replication and transformation. The remaining defects are in late functions; one is in the src gene affecting transformation (29), and the other two are in genes required for virus replication (2, 9, 15, 17, 25) . Previously, the defects of LA338 were shown to be due to separate lesions rather than a single coordinate mutation by the generation of recombinants between LA338 and wild-type RSV PR-B (9) . One of these recombinants, LA3382, has only the early defect and the lesions that impair virus replication at 410C. This recombinant has been used for biochemical characterizations of the late replication defect in LA338 since it has a wild-type src gene. Therefore, it has the advantage that it transforms cells at both the nonpermissive temperature (4100) and the permissive temperature (3500) if the early defect is avoided by initiating infection at 350C. Thus, the polypeptide compositions of the mutant and wildtype virions produced at the elevated temperature can be compared more accurately since the cells are physiologically similar. The data described here indicated that the major defect which impairs replication of LA3382 at 410C is in the biosynthesis of the env gene products. The mutation appears to result in aberrent cleavage of Pr95, the precursor of the virion glycoproteins, so that gp85 and gp37 are absent from the virus particles but can be identified in the culture supernatants. Although biosynthesis purchased from SPAFAS Inc., Norwich, Conn. C/BE fibroblasts (Kimber) were kindly provided by Carlo Moscovici. Only cells negative for chick helper factor (chf-) were used. The cell culture techniques and the chf tests used have been described previously (7) . The medium used consisted of Hams Fld medium supplemented with 10% tryptose phosphate broth, 5% calf serum, 6 .6 mM sodium bicarbonate, 100U of penicillin per ml, and 100 ug of streptomycin per ml. Polybrene (2 jg/ml) was used to enhance virus adsorption, and 1% dimethyl sulfoxide was added for transformed cell cultures.
Cloned RSV PR-C was used as a control in all experiments. Temperature-sensitive mutants of RSV PR-C and avian sarcoma virus B77 (LA335, LA3342, and LA3382) were obtained as described previously (9, 25) .
The titers of infectious viruses were determined by focus and replication assays (7) . Assays for reverse transcriptase (polymerase) activity were performed as described by Tereba and Murti (20) . Competition radioimmunoassays were used to quantitate virus for the polymerase assay (1). Infectious center assays were performed as previously described (23 (18) .
Virus purification. The medium was removed from each infected cell culture and clarified by centrifugation with a model J6 centrifuge (Beckman Instruments, Inc., Palo Alto, Calif.) for 10 min at 5,000 rpm. The clarified supernatants were loaded onto discontinuous 40% (wt/wt) potassium tartrate-20% (wt/ wt) sucrose gradients, and the viruses were recovered from the gradient interfaces after centrifugation at 40,000 rpm for 90 min in a Beckman SW41 rotor. The virus bands were diluted with buffer, pelleted in an SW41 rotor at 40,000 rpm for 60 min, and suspended in a small volume for electrophoresis (8) .
Immunoprecipitation of viral polypeptides. After the labeling period and after the medium was removed, 1 ml of lysis buffer A (1% Triton X-100, 1% sodium deoxycholate, 25 for the first 24 h of infection significantly reduced the efficiency of transformation and replication by LA3382 in a manner similar to the early reverse transcriptase mutant LA335. Wildtype PR-C and LA3342, which has only a late replication defect, transformed and replicated normally under these conditions. Thus, the early defect in LA3382 appeared to prevent the establishment of infection by the virus at 41°C, which would be expected to prevent both replication and transformation. The difference between these results and those reported previously presumably reflected the stringency of the experimental approaches that were used.
LA3382 tranformed chicken cells normally at 41°C if infection was initiated at 35°C, but was not able to produce infectious progeny under these conditions (Table 2 ). This late reversible defect was particularly interesting, and experiments to define its molecular nature are described below. In these experiments the effect of the early lesion was avoided by initiating all infections at 35°C and shifting to 41°C after all cells were infected in order to assay for biological and biochemical properties.
Production of particles by mutant-in- (Fig. 1) . In contrast, LA334, which has a temperature-sensitive defect in processing of the gag gene product, yields virus with a heterogenous density at the nonpermissive temperature (8 rupted, and electrophoresed on polyacrylamide gels (Fig. 2) . The polypeptide patterns ofLA3382 and wild-type PR-C virions produced at 350C
were very similar. In addition to the major internal structural proteins p27, p19, p12, and p15, two major glucosamine-labeled glycoproteins, gp85 and gp37, were present. At 410C wild-type PR-C exhibited a similar pattern, except that about four times as much virus was made and there was an enhanced incorporation of sugar label into gp85 and gp37 at the higher temperature. The synthesis of mutant LA3382 virions was also greater at 410C, but the polypeptide profile was significantly altered. Normal amounts of the non-glycosylated polypeptides were present, but the amounts of gp85 and gp37 appeared to be reduced significantly. Thus, the noninfectious virions produced at the restrictive temperature lacked the glycoproteins necessary for attachment and penetration of target cells. (Fig. 4) . The polyacrylamide gel patterns of LA3382 and PR-C grown at 35°C indicated that most of the labeled, cell-associated glycoprotein was in the form of the precursor, Pr95. Very little gp85 or gp37 was detected in association with the cells at the lower temperature. On the other hand, at 41°C a significant portion of the cell-associated glycoprotein precursor Pr95 of PR-C was cleaved to gp85 and gp37, which were still associated with the cells. However, this cleavage of the glycoprotein precursor was not observed at the nonpermissive temperature in LA3382-infected cells, where most of the labeled glycoprotein still migrated with Pr95. These results indicated that the gly- glucosamine, and samples of labeling medium from which the virus had been removed by highspeed centrifugation were immunoprecipitated and electrophoresed (Fig. 5B ). When these patterns were compared with the patterns of immunoprecipitates from noncentrifuged medium containing both virus-associated and free glycoproteins (Fig. 5A) , there was a significant difference between the mutant and wild-type virus culture supernatants. All of the glycoprotein found in the supernatant of LA3382-infected cells at 410C appeared to have been dissociated from the virions, in contrast to supernatants containing mutant virus released at 350C or wild-type virus produced at either temperature, where most of the gp85 was virion associated. Thus, it appeared that the mutant viral glycoproteins were released into the supernatant medium at 41°C, perhaps due to an aberrant cleavage or to a failure to form disulfide linkages. The glycoprotein which was released into the supernatant was indistinguishable from the gp85 of the virion, as determined by polyacrylamide gel electrophoresis. Whether the mutant glycoprotein was released from infected cells or from nascent virions could not be determined in this experiment.
Pr95 is incorporated into mutant virions. To determine whether the glycoprotein was released from infected cells or nascent virions, cells were pulsed for 15 after a 2-h chase released virus was purified and electrophoresed (Fig. 6) . The glycoproteins present in virions purified after the 2-h chase differed in the mutant and the wild type. At 350C the predominant form of the virion glycoprotein was Pr95 for both the mutant (Fig. 6, lane 3) and the wild type (lane 1) (although it was less obvious in the latter); this is in contrast to the long-term labeling conditions (Fig. 2) , where gp85 and gp37 predominated. At the higher temperature, however, proteolytic cleavage appeared to occur more rapidly, and a large proportion of the glycoprotein present in wild-type virions was in the mature form (i.e., gp85 and gp37) (Fig. 6, lane  2) . However, LA3382 virions contained predominantly Pr95 at 410C (lane 4), and the maintainance of gp85 and gp37 in these virions at the nonpermissive temperature was impaired significantly. These data indicated that the mutant precursor glycoprotein was synthesized at 410C and could be incorporated into virions. However the defective step appeared to be at the time of cleavage of the presursor, when gp85 and probably a portion of gp37 were released from the virions into the culture fluids. VOL. 40, 1981 on June 29, 2017 by guest http://jvi.asm.org/ Downloaded from LA3382 has a defective polymerase gene. It should be noted that the precursor of the reverse transcriptase (Pr180) in LA3382 was not processed as efficiently in infected cells at 410C as it was at 350C or in PR-C infected cells (Fig.  3) . When the polymerase activity of purified virions was examined, LA3382 grown at 410C showed approximately a twofold reduction in specific activity compared with LA3382 virions synthesized at 350C (Table 3) tures. From these results it seemed evident that the lesion responsible for the major replication defect in LA3382 is located within the env gene. DISCUSSION The temperature-sensitive mutant LA3382, a recombinant between LA338 and PR-B, retains three of the four defects of LA338 (only the transformation defect in src is missing) (9) . We used LA3382 to study these defects because it can transform cells at both the permissive temperature (3500) and the nonpermissive temperature (4100) and, therefore, can be compared with a wild-type control more accurately. Through the use of an infectious center assay (23), the early lesion was shown to impair both replication and transformation, as expected of an early defect (Table 1) . Previously, this had been difficult to demonstrate apparently because of the assay methods used and the leakiness in the expression of this lesion. Moelling and Friis (15) showed that the polymerase of LA338 was about fourfold more thermolabile than the polymerase of wild-type virus when it was assayed at 470C. These authors concluded that the early lesion was located in the pol gene and caused the input viral polymerase to be thermolabile. In contrast, Verma et al. (21) could not demonstrate any thermolabile properties for the LA338 enzyme and, therefore, suggested that the early lesion might be in env and might act at a stage before transcription, such as adsorbtion or penetration. This defect in LA3382 has not been defined unequivocally yet, but preliminary results (Hunter, unpublished data) have suggested that it may resemble the defect of another early mutant, LA30, which has a lesion in the env gene that affects adsorption and penetration of the virus (19) . The experiments with LA3382 described above strongly suggest that the late defect in replication is due to a lesion in the env gene.
LA3382 virions produced at 410C contain significantly reduced amounts of gp85 and gp37 compared with virus released at 350C or wild-type virus (Fig. 2) . When intracellular viral polypeptides were examined by pulse-chase experiments, the processing of Pr76 (the precursor of the internal structural proteins) occurred equally well at 35 and 410C in mutant-infected cells, but the glycoprotein precursor (Pr95) was processed more slowly in mutant-infected cells at 410C (Fig. 3) . At 350C, under long-term labeling conditions most of the cell-associated viral glycoprotein in either mutant or wild-type virus-infected cells was found in the form of the precursor, Pr95. This is consistent with a previous report (10) that cleavage of the glycoprotein precursor is extracellular. Whether this cleavage occurs on the surface of the cell or after release of the virus may depend on the culture temperature, since at 410C most of the cell-associated glycoprotein in PR-C-infected cells is in the form of the cleavage products gp85 and gp37. However, this is not the case in LA3382-infected cells, where at 410C most of the cell-associated glycoprotein remains uncleaved (Fig. 4) . Despite the apparent lack of proteolytic cleavage, we observed no accumulation of the mutant precursor in infected cells. Instead of accumulation or degradation, it appeared that the glycoprotein was released into the supernatant fluid upon cleavage of the precursor (Fig. 5 ). This could have been the result of an aberrant cleavage of the precursor or could have been due to an instability of the gp85-gp37 complex, since the glycoprotein found in the supernatant was indistinguishable from virion gp85. However, the lack of gp37 in the noninfectious virus released at 410C favored the former mechanism.
When virus was harvested from cells 2 h after a pulse-label with [3H]leucine, it was clear that both mutant and wild-type virions incorporated Pr95 at 350C (Fig. 6) the culture medium. Previous studies of recombination between LA338 and PR-B in which wild-type recombinants with the host range of the mutant were obtained at a high frequency suggested that the genetic lesion is not linked to the region of the env gene that determines host range (9) . A mutation in the gp37 region of the gene would be consistent with such results.
LA3382 has an additional defect in the pol gene since the polymerase precursor (Prl80) is clearly processed less efficiently at 41 than at 35°C (Fig. 3) . Coincident with this observation, a twofold reduction in reverse transcriptase activity was observed in mutant virions synthesized at 41°C (Table 3) . Panet et al. (17) also demonstrated that LA338 virions produced at 41°C contained about one-half as much polymerase as virions produced at 35°C, which is consistent with our results. These authors suggested that LA338 contains one lesion in the pol gene which is responsible for both the early defect and the late replication defect. Although a complementation assay with a mutant deleted in pol alone would be required to quantitate the effect of the polymerase defect, the reduced activity of the mutant polymerase is probably too small to account for the significant reduction in infectivity observed at 41°C. To establish that the major defect is located in the env gene, we showed that LA3382 was not complemented by RSV(-), which contains a deletion that spans most of the env gene but contains a normal pol gene (Table   4 ). Furthermore, we have observed that revertant clones of LA3382 (those that replicate at 41°C) produce mature glycoproteins but are still deficient in polymerase protein; this is additional evidence that the lesion responsible for the defect in replication is within the env gene.
It is of interest that growing LA3382 on C/O chicken cells (Hyline) in which low levels of chf expression can be detected results in the loss of the temperature-sensitive phenotype and the appearance of what we presume to be recombinant, glycoprotein-containing viruses at 41°C. Since repeated freezing and thawing of LA3382 stocks results in the gradual loss of infectivity and the temperature-sensitive phenotype, it is possible that even the virus glycoprotein synthesized at 35°C is less stable and that the revertant or recombinant viruses in the stock are selected.
